Objectives: To examine growth, sedation needs, and participation in developmental activities before and after tracheostomy among infants with severe bronchopulmonary dysplasia.
| INTRODUCTION
Bronchopulmonary dysplasia (BPD) is the most common chronic complication associated with preterm birth and is a strong predictor of childhood growth failure and neurodevelopmental developmental delay. [1] [2] [3] [4] [5] Infants with severe BPD often require prolonged and intensive pulmonary care. Among those with the most severe lung disease, this care may include tracheostomy and long-term invasive mechanical ventilation (MV). [6] [7] [8] Recently, both the Children's Hospital Neonatal Consortium and the BPD Collaborative reported tracheostomy rates of 12% in infants with severe BPD cared for in tertiary neonatal centers. 9, 10 Decisions about whether and when to place a tracheostomy are difficult for both families and clinicians. Tracheostomy has traditionally been viewed as a negative neonatal outcome owing in part to it being associated with increased risk for death or neurodevelopmental impairment (NDI) in preterm infants. 11, 12 However, causality is difficult to show. Previous data have demonstrated that BPD itself is an independent risk factor for NDI in extremely low birth weight infants 13 and a protracted course of mechanical ventilation is associated with increased mortality and neurodevelopmental disability in this population. 14, 15 In addition, earlier tracheostomy placement among infants who are likely to undergo tracheostomy may confer benefit. 16 Tracheostomy enables long-term, stable delivery of adequate positive airway pressure that may reduce work of breathing and promote growth. Additional benefits may be minimization of agitation and airway injury caused by conventional endotracheal tube and greater ease of movement and safer participation in developmental therapy. Currently, there are no data describing the association between tracheostomy placement and change in developmental or nutritional status in preterm infants with severe BPD. The purpose of this study is to address these knowledge gaps by evaluating short-term changes in growth, respiratory support needs, tolerance of developmental care, and daily sedation requirements before and after tracheostomy in infants with severe BPD.
We hypothesize that the study infants would demonstrate improved growth and participation in developmental activities post tracheostomy.
2 | METHODS
| Subjects
Data on all preterm infants with severe BPD (as per the NIH consensus definition) 17 
| Outcomes and data collection
Study data were obtained from the NeoCLD database or abstracted directly from the medical record. We compared the following study outcomes recorded during the 4-week period before tracheostomy placement to those recorded during 4-week period after the first tracheostomy tube change (performed 7 days after surgery): (1) growth velocity, defined as the average weekly change in weight, length, and head circumference; and (2) the proportion of attempted developmental therapy sessions that were able to performed (ie, the infant tolerated at least minimal handling) and the specific activities performed during the sessions. We did not include the 1-week period immediately after tracheostomy placement in our analysis as patients are typically heavily sedated and occasionally paralyzed during this time at our institution. In addition, we compared respiratory severity scores (RSS; mean airway pressure × FiO 2 recorded at 8-10 a.m.) 18 7 days before tracheostomy placement, on the day of surgery, 7 days after surgery, and 4 weeks after the first tracheostomy change. As part of our assessment of pre-and post-operative growth, we also calculated weight and length Z scores for each infant at birth, 4 weeks before tracheostomy, on the day of surgery, 4 weeks after the first tracheostomy tube change, and at the time of NICU discharge. Weight-for-length Z scores and total daily caloric intake (kcal/kg/day) were recorded for these same time points except the day of birth. Normative values for the weight-for-length are not available for preterm infants at birth.
All developmental therapy at our institution is performed by 
| Statistical analyses
Demographic and clinical data were summarized with standard descriptive statistics. Paired Student's t-tests were used to compare pre-and post-operative change in growth velocity, participation in developmental therapy, RSS, and sedation needs. Wilcoxon signedrank tests were used to compare anthropometric z-scores. A statistically significant difference was defined as a P-value <0.05. 3 | RESULTS
| Characteristics of the study population
A total of 318 premature infants diagnosed with severe BPD were admitted to our program during the study period, of which 91 (29%) underwent tracheostomy. We excluded 19 patients, leaving 72 infants for inclusion in the study cohort. Reasons for exclusion included receiving tracheostomy primarily for upper airway obstruction, not severe BPD (1 infant), gestational age >32 weeks' and birth weight >1500 g (3 infants), tracheostomy placement prior to transfer to our institution (12 infants, 3 of whom died prior to discharge from our hospital), death within 1 week of tracheostomy at our institution (2 infants) and severe congenital heart disease (1 infant who died several months post tracheostomy) . Demographic and clinical data for the 72 evaluated infants are summarized in Table 1 . The study cohort included 72 infants who had tracheostomy placement for long-term ventilation due to sBPD. Ninteen infants with sBPD and tracheostomy were excluded: one received tracheostomy mainly for airway stenosis, twelve transferred to our institution with tracheostomy already in place (three died prior to discharge), and three received tracheostomy at our institution but did not survive.
| Growth
The majority of the patients in this cohort were born appropriate for gestational age or following modest in-utero growth restriction However, 24% of infants still had length Z score less than −3 at the time of NICU discharge (Table 3 ).
When the growth velocity was compared over the 4-week period before tracheostomy and 4 weeks after the first tracheostomy tube change, the average weekly increase in weight, length and head circumference were significantly greater post compared to prior to tracheostomy placement (Table 2) . Of note, this improvement in growth was not associated with higher caloric intake. On the contrary, the study infants received significantly less calories per day post tracheostomy to achieve the observed improvement in growth (106.89 ± 17.01 vs 93.84 ± 16.52 kcal/kg/d, P < 0.001, Figure 1 and Table 2 ). LT, length, WT, weight. *P < 0.001 when compared to data at the time of tracheostomy.
| Developmental activity
More developmental therapy sessions were attempted and performed during the 4-week period following the first tracheostomy change as compared to the 4 weeks prior to the procedure (Table 2 ).
In addition, fewer sessions post tracheostomy were limited by decompensation in respiratory status (35% post vs 76% pretracheostomy, P < 0.0001) or required the therapist to facilitate state control (34% post vs 61% pre-trachesotomy, P < 0.0001). 
| Respiratory support
Ventilator settings at the time of tracheostomy placement were a mean MAP 14.8 ± 4.7, PIP 26.6 ± 7.3, PEEP 10.5 ± 3.5, and FiO 2 0.48 ± 0.09. There was no significant change in ventilator support and the mean RSSs were not different after tracheostomy placement as compared to before surgery (Mean RSSs 7 days before, the day of and 7 days after tracheostomy placement were 6.8 ± 3.6, 7.0 ± 3.2, and 6.0 ± 2.3) ( Table 4) .
| Tracheostomy complications
The most common post-operative complication was skin breakdown and/or soft tissue infection at the tracheostomy site (20%). Two patients had significant increases in supplemental oxygen requirements in the immediate post-operative period prompting initiation of inhaled nitric oxide and dexamethasone. One patient received a red blood cell transfusion on post-operative day 1 for a decrease in hemoglobin concentration from 10.6 to 7.8 g/dL without apparent clinical bleeding. Three patients who underwent tracheostomy at our institution died prior to discharge and were excluded from the analysis.
Of these, two had care withdrawn due to the severity of their illness and anticipated poor long-term outcome. One died of sudden cardiac arrest 4 days post-surgery. In this patient, there was no increase in ventilator settings post-surgery; tracheostomy obstruction or accidental decannulation were excluded by chest x-ray and emergency bedside bronchoscopy.
| Sedation medications
Fifty-seven patients (79% of the full study cohort) had complete sedation medication data available for evaluation. Each received scheduled (not "as needed") sedation medications during the 24-h period prior to tracheostomy; 51 (89%) were treated with both 
| DISCUSSION
The present study compared respiratory, growth, developmental activity, and daily sedation requirements before and after tracheostomy placement in a quaternary referral population of preterm infants with established, severe BPD. Most infants in this cohort were outborn and transferred to our institution following prolonged high level respiratory support. In this high-risk population, of whom approximately one-third undergo tracheostomy at out institution, tracheostomy placement was associated with improvement in growth (with decreased caloric need), greater tolerance of developmental therapy and a reduction in sedation medication exposure. To our knowledge, this study is the first to evaluate the change in these clinically relevant parameters before and after tracheostomy in very preterm infants with severe BPD.
Many parents and clinicians view tracheostomy placement in preterm infants as a negative clinical outcome. Worries include that it increases caregiver burden and is associated with increased risk of death and neurologic impairment. However, for some babies with severe lung and/or airway disease, tracheostomy may be the only means to facilitate a safe, timely transition to home. DeMauro et al., 16 using data from the US Neonatal Research Network, found that tracheostomy placement in extremely preterm infants was associated with increased risk-adjusted rates of cognitive and motor delay. Notably, however, tracheostomy placement prior to approximately 4 months of age (<120 days) compared to after this time point, was associated with a 50% reduction in the odds of death or neurodevelopmental impairment. 16 The investigators suggested this observation may be due, at least in part, Finally, in our experience, tracheostomy improves parents' ability to hold and play with their infant with less interruption due to clinical instability and with less assistance from healthcare practitioners.
In addition to delayed participation in developmentally appropriate activities, infants with severe BPD are at high risk for growth failure. 22 While most clinicians focus on weight gain, less attention is paid to linear growth. Unfortunately, infants who do not achieve appropriate linear growth are at increased risk of adverse neurodevelopment and reduced postnatal gains in lung function. 23, 24 Our data are consistent with previous data showing that poor linear growth is particularly common in infants with severe BPD. 5 Although most infants in our cohort were born appropriate for gestational age, nearly all were growth restricted, particularly with profound deficits in linear growth, before tracheostomy placement. Post-tracheostomy, we observed significant improvements in weight, length, and head growth.
This change was most notable for linear growth, with most infants demonstrating improvement in weight-to-length ratio and length Z scores post-tracheostomy. These changes in growth occurred despite no overall change in pre-and post-operative respiratory severity scores and a decrease in caloric intake. We speculate that the improved growth following tracheostomy may result from decreased stress and agitation (and thus less work of breathing and energy expenditure) following exchange of a less secure oral/nasal endotracheal tube for a more stable and comfortable tracheostomy.
In this cohort, tracheostomy placement was clinically well tolerated in the majority of infants. The most common post-operative complication was skin breakdown and/or soft tissue infection at the tracheostomy site, occurring in less than one-quarter of infants.
Overall, mortality prior to hospital discharge was low and no deaths Our study has several limitations. In particular, is its retrospective nature and reliance on data obtained through chart review. In addition, we cannot assess whether the observed changes in developmental therapies and growth before and after tracheostomy resulted, at least in part, from temporal change (eg, gradual improvement over time) in these outcomes. Finally, these results only reflect data from a single center. Confirmation in a larger, multi-center cohort is needed.
Nonetheless, our study provides short-term outcome data for a relatively large, contemporary cohort of infants who underwent tracheostomy placement for severe BPD.
In conclusion, our findings suggest that in infants with severe BPD who require prolonged high level respiratory support beyond term corrected gestation, tracheostomy placement is safe and may have beneficial effects on growth and short-term development. When clinicians and parents are trying to decide whether or not to place tracheostomy, these potential beneficial effects should be taken into consideration along with other benefits and balanced against the risks and caregiver burden of tracheostomy. Further studies are needed to determine the best timing of tracheostomy placement in this population.
